MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
0.2300
-0.1826
-44.26%
Opening 12:37 02/12 EST
OPEN
0.2339
PREV CLOSE
0.4126
HIGH
0.2700
LOW
0.2195
VOLUME
8.45M
TURNOVER
--
52 WEEK HIGH
2.500
52 WEEK LOW
0.2195
MARKET CAP
2.04M
P/E (TTM)
-0.1557
1D
5D
1M
3M
1Y
5Y
1D
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall
Benzinga · 3h ago
BioRestorative Therapies prices $5.0M public offering of common stock at $0.35
TipRanks · 6h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 6h ago
Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Benzinga · 9h ago
BioRestorative prices $5M stock offering
Seeking Alpha · 13h ago
*BioRestorative Therapies Prices 14.3M Shares, Warrants to Purchase Up to 14.3M Shares at Combined Public Offering Price of $0.35/Share >BRTX
Dow Jones · 15h ago
*BioRestorative Therapies Expects Offering to Close on or About Feb. 13 >BRTX
Dow Jones · 15h ago
*BioRestorative Therapies Plans to Use Net Proceeds for Clinical Trials, Preclinical R&D, Develop Commercial Biocosmeceuticals Platform >BRTX
Dow Jones · 15h ago
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.